MarketBeat Instant News Alerts 2 hours agoShoe Carnival (NASDAQ:SHOE) Releases FY 2026 Earnings GuidanceMarketBeatShoe Carnival (NASDAQ:SHOE) updated its FY 2026 earnings guidance. The company provided EPS guidance of 0.750-0.900 for the period. NASDAQ:SHOERead Shoe Carnival (NASDAQ:SHOE) Releases FY 2026 Earnings Guidance2 hours agoMacy's (NYSE:M) Updates FY 2026 Earnings GuidanceMarketBeatMacy's (NYSE:M) updated its FY 2026 earnings guidance. The company provided EPS guidance of 2.150-2.350 for the period, compared to the consensus estimate of 2.110. The company also issued revenue guidance of $21.7 billionillion-$21.8 billionillion, compared to the consensus estimate of $21.1 billionillion. NYSE:MRead Macy's (NYSE:M) Updates FY 2026 Earnings Guidance2 hours agoMacy's (NYSE:M) Issues Q3 2026 Earnings GuidanceMarketBeatMacy's (NYSE:M) updated its third quarter 2026 earnings guidance. The company provided EPS guidance of -0.230--0.190 for the period, compared to the consensus estimate of -0.120. The company also issued revenue guidance of $4.7 billionillion-$4.7 billionillion, compared to the consensus estimate of $4.7 billionillion. NYSE:MRead Macy's (NYSE:M) Issues Q3 2026 Earnings Guidance2 hours agoLovesac (NASDAQ:LOVE) Updates FY 2027 Earnings GuidanceMarketBeatLovesac (NASDAQ:LOVE) updated its FY 2027 earnings guidance. The company provided EPS guidance of 0.980-1.260 for the period, compared to the consensus estimate of 1.090. The company also issued revenue guidance of $690.0 millionillion-$710.0 millionillion, compared to the consensus estimate of $716.8 millionillion. NASDAQ:LOVERead Lovesac (NASDAQ:LOVE) Updates FY 2027 Earnings Guidance2 hours agoLovesac (NASDAQ:LOVE) Updates Q3 2027 Earnings GuidanceMarketBeatLovesac (NASDAQ:LOVE) updated its third quarter 2027 earnings guidance. The company provided EPS guidance of 0.620-0.830 for the period, compared to the consensus estimate of -0.560. The company also issued revenue guidance of $140.0 millionillion-$150.0 millionillion, compared to the consensus estimate of $156.7 millionillion. NASDAQ:LOVERead Lovesac (NASDAQ:LOVE) Updates Q3 2027 Earnings Guidance2 hours agoHC Wainwright Reiterates "Buy" Rating for BridgeBio Pharma (NASDAQ:BBIO)MarketBeatHC Wainwright reiterated a "buy" rating and set a $120.00 target price on shares of BridgeBio Pharma in a research report on Thursday.NASDAQ:BBIORead HC Wainwright Reiterates "Buy" Rating for BridgeBio Pharma (NASDAQ:BBIO) Trending News1BlackRock Inc. Acquires New Stake in Tilray Brands, Inc. $TLRY2Vertiv (NYSE:VRT) Stock Price Down 5.9% - Here's Why3Saudi Central Bank Raises Stock Holdings in Nebius Group N.V. $NBIS4Advanced Micro Devices Sees AI Boom Fueling MI450, Helios and Server CPU Growth5UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Holdings in Plug Power, Inc. $PLUG6Fermi (NASDAQ:FRMI) Trading Up 7.9% - Here's What Happened7Saudi Central Bank Increases Stock Position in Rocket Lab Corporation $RKLB8Formuepleje A S Sells 143,162 Shares of HDFC Bank Limited $HDB All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours ago908 Devices (NASDAQ:MASS) Now Covered by Canaccord Genuity GroupMarketBeatNASDAQ:MASSRead 908 Devices (NASDAQ:MASS) Now Covered by Canaccord Genuity Group2 hours agoCenterspace's (CSR) "Neutral" Rating Reiterated at Cantor FitzgeraldMarketBeatNYSE:CSRRead Centerspace's (CSR) "Neutral" Rating Reiterated at Cantor Fitzgerald2 hours agoNorthland Securities Initiates Coverage on Fervo Energy (NASDAQ:FRVO)MarketBeatNASDAQ:FRVORead Northland Securities Initiates Coverage on Fervo Energy (NASDAQ:FRVO)2 hours agoCTS (NYSE:CTS) Now Covered by Barrington ResearchMarketBeatNYSE:CTSRead CTS (NYSE:CTS) Now Covered by Barrington Research2 hours agoHC Wainwright Has Bullish Forecast for ASMB FY2028 EarningsMarketBeatNASDAQ:ASMBRead HC Wainwright Has Bullish Forecast for ASMB FY2028 Earnings2 hours agoZacks Research Has Bullish Forecast for ITW Q2 EarningsMarketBeatNYSE:ITWRead Zacks Research Has Bullish Forecast for ITW Q2 Earnings2 hours agoZacks Research Lowers Earnings Estimates for Alliant EnergyMarketBeatNASDAQ:LNTRead Zacks Research Lowers Earnings Estimates for Alliant Energy2 hours agoTyra Biosciences (NASDAQ:TYRA) Price Target Cut to $30.00 by Analysts at HC WainwrightMarketBeatNASDAQ:TYRARead Tyra Biosciences (NASDAQ:TYRA) Price Target Cut to $30.00 by Analysts at HC Wainwright2 hours agoHC Wainwright Reaffirms Buy Rating for Seaport Therapeutics (NASDAQ:SPTX)MarketBeatNASDAQ:SPTXRead HC Wainwright Reaffirms Buy Rating for Seaport Therapeutics (NASDAQ:SPTX)2 hours agoRosenblatt Securities Reiterates Neutral Rating for SailPoint (NASDAQ:SAIL)MarketBeatNASDAQ:SAILRead Rosenblatt Securities Reiterates Neutral Rating for SailPoint (NASDAQ:SAIL)2 hours agoPyxis Oncology (NASDAQ:PYXS) Price Target Raised to $8.00MarketBeatNASDAQ:PYXSRead Pyxis Oncology (NASDAQ:PYXS) Price Target Raised to $8.002 hours agoNavan (NASDAQ:NAVN) Given New $29.00 Price Target at Rosenblatt SecuritiesMarketBeatNASDAQ:NAVNRead Navan (NASDAQ:NAVN) Given New $29.00 Price Target at Rosenblatt Securities2 hours agoNavan's (NAVN) Buy Rating Reiterated at BTIG ResearchMarketBeatNASDAQ:NAVNRead Navan's (NAVN) Buy Rating Reiterated at BTIG Research2 hours agoImmunic's (IMUX) Buy Rating Reiterated at HC WainwrightMarketBeatNASDAQ:IMUXRead Immunic's (IMUX) Buy Rating Reiterated at HC Wainwright2 hours agoGarrett Motion (NASDAQ:GTX) Upgraded to "Strong-Buy" at Zacks ResearchMarketBeatNASDAQ:GTXRead Garrett Motion (NASDAQ:GTX) Upgraded to "Strong-Buy" at Zacks Research2 hours agoBTIG Research Boosts Equinix (NASDAQ:EQIX) Price Target to $1,240.00MarketBeatNASDAQ:EQIXRead BTIG Research Boosts Equinix (NASDAQ:EQIX) Price Target to $1,240.002 hours ago8X8 (NASDAQ:EGHT) Given "Buy" Rating at Rosenblatt SecuritiesMarketBeatNASDAQ:EGHTRead 8X8 (NASDAQ:EGHT) Given "Buy" Rating at Rosenblatt Securities2 hours agoMastercraft Boat (NASDAQ:MCFT) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPSMarketBeatNASDAQ:MCFTRead Mastercraft Boat (NASDAQ:MCFT) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS2 hours agoLovesac (NASDAQ:LOVE) Announces Quarterly Earnings Results, Beats Estimates By $0.87 EPSMarketBeatNASDAQ:LOVERead Lovesac (NASDAQ:LOVE) Announces Quarterly Earnings Results, Beats Estimates By $0.87 EPS2 hours agoVince (NASDAQ:VNCE) Posts Quarterly Earnings Results, Beats Expectations By $0.76 EPSMarketBeatNASDAQ:VNCERead Vince (NASDAQ:VNCE) Posts Quarterly Earnings Results, Beats Expectations By $0.76 EPS2 hours agoShoe Carnival (NASDAQ:SHOE) Releases Earnings Results, Misses Estimates By $0.10 EPSMarketBeatNASDAQ:SHOERead Shoe Carnival (NASDAQ:SHOE) Releases Earnings Results, Misses Estimates By $0.10 EPS2 hours agoTHG (LON:THG) Issues Earnings ResultsMarketBeatLON:THGRead THG (LON:THG) Issues Earnings Results2 hours agoOakley Capital Investments (LON:OCI) Releases Earnings ResultsMarketBeatLON:OCIRead Oakley Capital Investments (LON:OCI) Releases Earnings Results2 hours agoGenus (LON:GNS) Releases Quarterly Earnings ResultsMarketBeatLON:GNSRead Genus (LON:GNS) Releases Quarterly Earnings Results Featured Articles and OffersTesla’s Robotaxi Launch Wasn’t the Moment Investors ExpectedBy Sam Quirke | September 8, 2026This sub-5 dollar stock operates next to SpaceX and Blue OriginFrom Freedom Financial (Ad)AI Token Costs Are Changing the Hardware vs. Software DebateBy Jeffrey Neal Johnson | September 6, 2026Ride-Share Reckoning: Tesla Drives Into Uber's LaneBy Jeffrey Neal Johnson | September 7, 2026The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth StoryBy Leo Miller | September 3, 2026Bezos… DOOMEDFrom Paradigm Press (Ad)3 Under-the-Radar Defense Stocks With Record BacklogsBy Dan Schmidt | September 7, 2026NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat NowBy Jeffrey Neal Johnson | September 3, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 401 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
